Association of human papillomavirus type 58 with breast cancer in shaanxi province of China

Journal of Medical Virology

Volumn 87, Issue 6, 2015, Pages 1034-1040

  Fu, Ling ^a   Wang, Depu ^a   Shah, Walayat ^b   Wang, Yili ^a   Zhang, Guanjun ^a   He, Jianjun ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b KHYBER MEDICAL UNIVERSITY   (Pakistan)

Author keywords

Breast cancer; High risk human papillomavirus; HPV 58; ISH; PCR

Indexed keywords

FORMALDEHYDE; PROTEIN P16; VIRUS DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PRIMER DNA;

ADULT; ARTICLE; BREAST CANCER; BREAST LESION; CANCER CELL; CANCER TISSUE; CARCINOMA IN SITU; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; VIRUS DETECTION; VIRUS LOAD; AGED; ALPHAPAPILLOMAVIRUS; FEMALE; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PAPILLOMAVIRUS INFECTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 58;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, SQUAMOUS CELL; CHINA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 84926513785     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24142     Document Type: Article

References (38)

1. Akhter J, Aziz MAA, Al Ajlan A, Tulbah A, Akhtar M. 2014. Breast cancer: Is there a viral connection? Adv Anat Pathol 21:373-381.
2. Band V, Zajchowski D, Kulesa V, Sager R. 1990. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 87:463-467.
3. Bohn OL, Fuertes-Camilo M, Navarro L, Saldivar J, Sanchez-Sosa S. 2010. P16INK4a expression in basal-like breast carcinoma. Int J Clin Exp Pathol 3:600-607.
4. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi FE, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L. 2009. A review of human carcinogens-Part B: Biological agents. Lancet Oncol 10:321-322.
5. Chan PK, Ho W, Yu MY, Pong WM, Chan AC, Chan AK, Cheung TH, Wong M, To KF, Ng HK. 2009. Distribution of human papillomavirus types in cervical cancers in Hong Kong: Current situation and changes over the last decades. Int J Cancer 125:1671-1677.
6. Chan PK, Luk AC, Park J-S, Smith-McCune KK, Palefsky JM, Konno R, Giovannelli L, Coutlée F, Hibbitts S, Chu T-Y. 2011. Identification of human papillomavirus type 58 lineages and the distribution worldwide. J Infect Dis 203:1565-1573.
7. Chan PK, Zhang C, Park JS, Smith-McCune KK, Palefsky JM, Giovannelli L, Coutlée F, Hibbitts S, Konno R, Settheetham-Ishida W. 2013. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. Int J Cancer 132:2528-2536.
8. Chang P, Wang T, Yao Q, Lv Y, Zhang J, Guo W, Wang L, Chen J. 2012. Absence of human papillomavirus in patients with breast cancer in north-west China. Med Oncol 29:521-525.
9. Cimino-Mathews A, Hicks JL, Sharma R, Vang R, Illei PB, De Marzo A, Emens LA, Argani P. 2013. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway. Hum Pathol 44:2494-2500.
10. de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE. 2005. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 7:R1-11.
11. Di Lonardo A, Venuti A, Marcante ML. 1992. Human papillomavirus in breast cancer. Breast Cancer Res Treat 21:95-100.
12. Ding DC, Hsu HC, Huang RL, Lai HC, Lin CY, Yu MH, Chu TY. 2008. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: An indication of viral oncogenic potential. Eur J Obstet Gynecol Reprod Biol 140:245-251.
13. Feng B, Awuti I, Deng Y, Li D, Niyazi M, Aniwar J, Sheyhidin I, Lu G, Li G, Zhang L. 2013. Human papillomavirus promotes esophageal squamous cell carcinoma by regulating DNA methylation and expression of HLA-DQB1. Asia Pac J Clin Oncol 10:66-74.
14. Gopalkrishna V, Singh U, Sodhani P, Sharma J, Hedau S, Mandal A, Das B. 1996. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 39:197-202.
15. Gumus M, Yumuk P, Salepci T, Aliustaoglu M, Dane F, Ekenel M, Basaran G, Kaya H, Barisik N, Turhal N. 2006. HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res 25:515-521.
16. Hedau S, Kumar U, Hussain S, Shukla S, Pande S, Jain N, Tyagi A, Deshpande T, Bhat D, Mir MM. 2011. Breast cancer and human papillomavirus infection: No evidence of HPV etiology of breast cancer in Indian women. BMC cancer 11:27.
17. Heng B, Glenn W, Ye Y, Tran B, Delprado W, Lutze-Mann L, Whitaker N, Lawson J. 2009. Human papilloma virus is associated with breast cancer. Br J Cancer 101:1345-1350.
18. Huang S, Afonina I, Miller BA, Beckmann AM. 1997. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70:408-411.
19. Hwang T. 1999. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 14:593-599.
20. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin 61:69-90.
21. Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K. 2013. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer Med 2:933-941.
22. Khokher S, Qureshi W, Mahmood S, Saleem A, Mahmud S. 2011. Knowledge, attitude and preventive practices of women for breast cancer in the educational institutions of Lahore, Pakistan. Asian Pac J Cancer Prev 12:2419-2424.
23. Lawson JS. 2009. Do viruses cause breast cancer? Methods Mol Biol 471:421-438.
24. Lawson JS, Heng B. 2010. Viruses and breast cancer. Cancers (Basel) 2:752-772.
25. Li N, Bi X, Zhang Y, Zhao P, Zheng T, Dai M. 2011. Human papillomavirus infection and sporadic breast carcinoma risk: A meta-analysis. Breast Cancer Res Treat 126:515-520.
26. Li H, Zhang J, Chen Z, Zhou B, Tan Y. 2013a. Prevalence of human papillomavirus genotypes among women in Hunan province, China. Eur J Obstet Gynecol Reprod Biol 170:202-205.
27. Li Y, Wang X, Ni T, Wang F, Lu W, Zhu J, Xie X, Zheng ZM. 2013b. Human papillomavirus type 58 genome variations and RNA expression in cervical lesions. J Virol 87:9313-9322.
28. Lindel K, Forster A, Altermatt HJ, Greiner R, Gruber G. 2007. Breast cancer and human papillomavirus (HPV) infection: No evidence of a viral etiology in a group of Swiss women. Breast 16:172-177.
29. Liu HY, Zhou SL, Ku JW, Zhang DY, Li B, Han XN, Fan ZM, Cui JL, Lin HL, Guo ET. 2014. Prevalence of human papillomavirus infection in esophageal and cervical cancers in the high incidence area for the two diseases from 2007 to 2009 in Linzhou of Henan Province, Northern China. Arch Virol 59:1393-1410.
30. Mohiuddin MK, Chava S, Upendrum P, Latha M, Zubeda S, Kumar A, Ahuja YR, Hasan Q, Mohan V, Stinchcombe TE. 2013. Role of Human papilloma virus infection and altered methylation of specific genes in esophageal cancer. Asian Pac J Cancer Prev 14:4187-4193.
31. Mooren JJ, Gültekin SE, Straetmans JM, Haesevoets A, Peutz-Kootstra CJ, Huebbers CU, Dienes HP, Wieland U, Ramaekers F, Kremer B. 2014. P16INK4A immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias. Int J Cancer 134:2108-2117.
32. Shah W, Hongwei C, Jin Z, Lifang D, Jun Y, Yili W. 2009. The prevalence of human papillomavirus type 58 in Chinese patients with cervical carcinoma and its influence on survival. Clin Oncol 21:768-774.
33. Subhawong AP, Subhawong T, Nassar H, Kouprina N, Begum S, Vang R, Westra WH, Argani P. 2009. Most basal-like breast carcinomas demonstrate the same Rb -/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol 33:163-175.
34. Subramaniam RM, Alluri KC, Tahari AK, Aygun N, Quon H. 2014. PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: Evolving clinical imaging paradigm. J Nucl Med 55:431-4388.
35. Thomas J, Primeaux T. 2012. Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 16:91-99.
36. Wang Y-Y, Li L, Wei S, Peng J, Yuan S-X, Xie J-S, Liu Z-H. 2013. Human Papillomavirus (HPV) infection in women participating in cervical cancer screening from 2006 to 2010 in Shenzhen City, South China. Asian Pac J Cancer Prev 14:7483-7487.
37. Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C. 2004. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 31:292-297.
38. Zhang XC, Xu C, Mitchell RM, Zhang B, Zhao D, Li Y, Huang X, Fan W, Wang H, Lerma LA. 2013. Tumor evolution and intratumor heterogeneity of an oropharyngeal squamous cell carcinoma revealed by whole-genome sequencing. Neoplasia 15:1371-1378.